Annual report 2023

Statement of changes in equity of medmix Ltd

thousands of CHF

 

Share capital

 

Reserves from capital contribution

 

Other capital reserves

 

Voluntary retained earnings

 

Treasury shares

 

Profit / (loss) brought forward

 

Profit / (loss) for the year

 

Total

Equity as of January 1, 2022

 

413

 

294’653

 

50’000

 

293’951

 

–6’489

 

 

–498

 

632’030

Allocation of free reserves

 

 

 

 

 

 

 

–25’000

 

 

 

25’000

 

 

 

Dividend

 

 

 

 

 

 

 

 

 

 

 

–20’457

 

 

 

–20’457

Allocation of net income

 

 

 

 

 

 

 

 

 

 

 

–498

 

498

 

Profit / (loss) for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

14’270

 

14’270

Change in treasury shares

 

 

 

 

 

 

 

 

 

–5’981

 

 

 

 

 

–5’981

Equity as of December 31, 2022

 

413

 

294’653

 

50’000

 

268’951

 

–12’470

 

4’045

 

14’270

 

619’862

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2023

 

413

 

294’653

 

50’000

 

268’951

 

–12’470

 

4’045

 

14’270

 

619’862

Allocation of free reserves

 

 

 

 

 

 

 

–5’000

 

 

 

5’000

 

 

 

Dividend

 

 

 

 

 

 

 

 

 

 

 

–20’454

 

 

 

–20’454

Allocation of net income

 

 

 

 

 

 

 

 

 

 

 

14’270

 

–14’270

 

Profit / (loss) for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

33’552

 

33’552

Change in treasury shares

 

 

 

 

 

 

 

 

 

–2’714

 

 

 

 

 

–2’714

Equity as of December 31, 2023

 

413

 

294’653

 

50’000

 

263’951

 

–15’184

 

2’861

 

33’552

 

630’246